The effect of the irreversible mu-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA.

[1]  K. Elliott,et al.  CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone , 1995, Brain Research Bulletin.

[2]  A. Duttaroy,et al.  The Effect of Intrinsic Efficacy on Opioid Tolerance , 1995, Anesthesiology.

[3]  M. Kreek,et al.  Mu opioid receptor mRNA levels following chronic naltrexone administration , 1994, Regulatory Peptides.

[4]  K. Elliott,et al.  Strain differences in the analgesic potency of morphine and in mu opioid receptor mRNA levels in adult male mice , 1994, Regulatory Peptides.

[5]  J. Woods,et al.  Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice. , 1994, The Journal of pharmacology and experimental therapeutics.

[6]  C. Inturrisi,et al.  Ethanol and naloxone differentially upregulate delta opioid receptor gene expression in neuroblastoma hybrid (NG108-15) cells. , 1994, Brain research. Molecular brain research.

[7]  J. Woods,et al.  In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  Lei Yu,et al.  Molecular cloning and functional expression of a mu opioid receptor from rat brain , 1994, Regulatory Peptides.

[9]  R. Edwards,et al.  Ethanol increases delta-opioid receptor gene expression in neuronal cell lines. , 1993, Molecular pharmacology.

[10]  S. Dworkin,et al.  Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections. , 1993, The Journal of pharmacology and experimental therapeutics.

[11]  C. Wahlestedt,et al.  Quantitation of NMDA receptor (NMDAR1) mRNA levels in the adult and developing rat CNS. , 1993, Brain research. Molecular brain research.

[12]  J. Woods,et al.  Clocinnamox: a novel, systemically-active, irreversible opioid antagonist. , 1992, The Journal of pharmacology and experimental therapeutics.

[13]  A. Duttaroy,et al.  Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation , 1992, Pharmacology Biochemistry and Behavior.

[14]  Yuan-Shan Zhu,et al.  Time course of enkephalin mRNA and peptides in cultured rat adrenal medulla. , 1992, Brain research. Molecular brain research.

[15]  L. Liu-Chen,et al.  Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociception , 1991 .

[16]  M. Aceto,et al.  Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives. , 1989, Arzneimittel-Forschung.

[17]  E. J. Simon,et al.  Effects of stress and beta-funal trexamine pretreatment on morphine analgesia and opioid binding in rats. , 1987, Life sciences.

[18]  E. J. Simon,et al.  Antagonist-induced opiate receptor upregulation in cultures of fetal mouse spinal cord-ganglion explants. , 1986, Brain research.

[19]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.